dr. hoimes on ev-103 results in urothelial cancer
Published 4 years ago • 81 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
1:07
dr. petrylak on the results of the ev-103 trial in bladder cancer
-
2:10
initial ev-103 results: enfortumab vedotin plus pembrolizumab for urothelial carcinoma
-
13:47
ev-103: enfortumab vedotin and pembrolizumab in urothelial carcinoma
-
6:02
ev-103: ev pembrolizumab as a promising first-line option for urothelial carcinoma
-
2:08
dr. david nanus on atezolizumab for urothelial bladder cancer
-
1:33
dr. balar on results of durvalumab plus tremelimumab in bladder cancer
-
0:54
dr. balar on results of keynote-052 in urothelial cancer
-
1:05
dr. sonpavde on the biggest challenges in bladder cancer
-
1:18
dr. hoffman-censits on biomarker development in urothelial carcinoma
-
2:07
dr. o’donnell on the evolution of immunotherapy in metastatic bladder cancer
-
1:21
dr. oh discusses updates in bladder cancer treatment
-
8:27
urothelial carcinoma: ev-301 update from asco 2022
-
1:36
dr. oh on results of chemotherapy versus arta in prostate cancer
-
0:51
dr. hoffman-censits on challenges with sequencing for urothelial carcinoma
-
0:51
addressing an unmet medical need in urothelial carcinoma
-
1:02
elucidating the biology of upper tract urothelial cancer
-
3:38
breakthroughs in urothelial cancer treatment at esmo 2023
-
2:37
updates in kidney and bladder cancers: 2023 west oncology